| Dr Michael Antoine, OD | |
|
2943 St. Louis Galleria, St. Louis, MO 63117-1113 | |
| (314) 862-1525 | |
| (314) 863-6218 |
| Full Name | Dr Michael Antoine |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 39 Years |
| Location | 2943 St. Louis Galleria, St. Louis, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588758098 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TO2663 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Antoine Eye Care, Llc | 8325147200 | 2 |
News Archive
Researchers from The University of Texas Medical Branch at Galveston have developed the first vaccine for chikungunya fever made from an insect-specific virus that doesn't have any effect on people, making the vaccine safe and effective.
IntegenX Inc. and Promega Corporation today announced that commercial deliveries of RapidHIT™ 200 Human Identification Systems will include Promega's nucleic acid purification and short tandem repeat (STR) amplification reagents.
Sangamo BioSciences, Inc. announced today that the California Institute for Regenerative Medicine (CIRM) has granted a $14.5 million Disease Team Research Award to develop an AIDS-related lymphoma therapy based on the application of its zinc finger nuclease (ZFN) gene-editing technology in stem cells.
OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic disorders and a subsidiary of Can-Fite BioPharma Ltd., announced today it has signed a definitive agreement to acquire Israel-based Improved Vision Systems Ltd. in a stock-for-stock transaction.
› Verified 6 days ago
| Provider Name | Antoine Eye Care, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1881772937 PECOS PAC ID: 8325147200 Enrollment ID: O20070618000202 |
News Archive
Researchers from The University of Texas Medical Branch at Galveston have developed the first vaccine for chikungunya fever made from an insect-specific virus that doesn't have any effect on people, making the vaccine safe and effective.
IntegenX Inc. and Promega Corporation today announced that commercial deliveries of RapidHIT™ 200 Human Identification Systems will include Promega's nucleic acid purification and short tandem repeat (STR) amplification reagents.
Sangamo BioSciences, Inc. announced today that the California Institute for Regenerative Medicine (CIRM) has granted a $14.5 million Disease Team Research Award to develop an AIDS-related lymphoma therapy based on the application of its zinc finger nuclease (ZFN) gene-editing technology in stem cells.
OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic disorders and a subsidiary of Can-Fite BioPharma Ltd., announced today it has signed a definitive agreement to acquire Israel-based Improved Vision Systems Ltd. in a stock-for-stock transaction.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Antoine, OD 2943 St. Louis Galleria, St. Louis, MO 63117-1113 Ph: (314) 862-1525 | Dr Michael Antoine, OD 2943 St. Louis Galleria, St. Louis, MO 63117-1113 Ph: (314) 862-1525 |
News Archive
Researchers from The University of Texas Medical Branch at Galveston have developed the first vaccine for chikungunya fever made from an insect-specific virus that doesn't have any effect on people, making the vaccine safe and effective.
IntegenX Inc. and Promega Corporation today announced that commercial deliveries of RapidHIT™ 200 Human Identification Systems will include Promega's nucleic acid purification and short tandem repeat (STR) amplification reagents.
Sangamo BioSciences, Inc. announced today that the California Institute for Regenerative Medicine (CIRM) has granted a $14.5 million Disease Team Research Award to develop an AIDS-related lymphoma therapy based on the application of its zinc finger nuclease (ZFN) gene-editing technology in stem cells.
OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic disorders and a subsidiary of Can-Fite BioPharma Ltd., announced today it has signed a definitive agreement to acquire Israel-based Improved Vision Systems Ltd. in a stock-for-stock transaction.
› Verified 6 days ago
Jeff Thompson, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 211 Watson Plaza, St. Louis, MO 63126 Phone: 314-821-2929 | |
Traci Lynne Kohm, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 9549 Watson Road, St. Louis, MO 63126 Phone: 314-651-3883 | |
Dr. Darci Lea Hunter Prewitt, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: Lenscrafters, 122a S County Center Way, St. Louis, MO 63129 Phone: 314-416-7588 Fax: 314-416-9368 | |
Dr. Mary Beth Rhomberg, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7840 Natural Bridge Rd, Patient Care Center, St. Louis, MO 63121 Phone: 314-516-5131 Fax: 314-516-5507 | |
Crown Optical Optometrist Medicare: Medicare Enrolled Practice Location: 10465 St. Charles Rock Road, St. Louis, MO 63074 Phone: 314-423-2010 Fax: 800-432-6004 | |
Dr. Jessica Tu, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7840 Natural Bridge Blvd, Patient Care Center, St. Louis, MO 63121 Phone: 314-516-5131 Fax: 314-516-5507 | |
Stephanie Lynn Cullinan, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3122 S Grand, St. Louis, MO 63118 Phone: 314-450-7313 |